[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy

  1. Ma, W.W.
  2. Jacene, H.
  3. Song, D.
  4. Vilardell, F.
  5. Messersmith, W.A.
  6. Laheru, D.
  7. Wahl, R.
  8. Endres, C.
  9. Jimeno, A.
  10. Pomper, M.G.
  11. Hidalgo, M.
Aldizkaria:
Journal of Clinical Oncology

ISSN: 0732-183X

Argitalpen urtea: 2009

Alea: 27

Zenbakia: 16

Orrialdeak: 2697-2704

Mota: Artikulua

DOI: 10.1200/JCO.2008.18.8383 GOOGLE SCHOLAR lock_openSarbide irekia editor

Objetivos de desarrollo sostenible

Datuen iturria: Scopus